Stockscreener 앱 받기
49.47
18.12%
7.59
시장 영업 전:
48.73
-0.74
-1.50%
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Why Hims & Hers Health, Inc. (HIMS) Skyrocketed On Tuesday - Yahoo Finance
Hims & Hers Stock (HIMS) Falls as Cautious Outlook Blurs Massive Revenue Growth - Yahoo Finance
Hims & Hers Health, Inc. Reports Strong Q1 Earnings - TipRanks
Hims & Hers Health (HIMS) Surges 18.12%: What’s Fueling the Rally? - Wealth Daily
Stock Movers: Palantir, Hims, Constellation Energy - Bloomberg.com
What’s driving the roller coaster ride for San Francisco’s Hims & Hers stock? - San Francisco Chronicle
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why - Yahoo Finance
Palantir, Tesla, Ford, Constellation Energy, SolarEdge, Vertex, DoorDash, and More Movers - Barron's
Wall Street Punishes HIMS--Right After It Lands a Blockbuster Weight Loss Deal - Yahoo Finance
Noteworthy Tuesday Option Activity: ROOT, HIMS, SN - Nasdaq
Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped - Nasdaq
2 Reasons Hims & Hers Will Break $50sBuy Post Earnings (NYSE:HIMS) - Seeking Alpha
HIMS Q1 Earnings Call: Personalized Care and New Partnerships Drive Upside, Guidance Signals Near-Term Transition - Yahoo Finance
HIMS Stock Dips Pre-Market Despite Q1 Earnings Beat, Gross Margin Down - TradingView
Piper Sandler Raises Price Target for Hims & Hers Health (HIMS) to $39.00 | HIMS Stock News - GuruFocus
Hims & Hers Health (HIMS) Price Target Raised by Citigroup | HIMS Stock News - GuruFocus
Hims surges, SolarEdge earnings beat, Rivian expands in Illinois - Yahoo Finance
Hims & Hers stock jumps after blowout quarter, long-term guidance stuns Street - Proactive financial news
Hims & Hers Stock Rises on Fundamentals and Squeeze Potential - MarketBeat
What's Going On With Hims & Hers Stock Tuesday? - Benzinga
Hims & Hers Q1 2025 slides: Sets $6.5B revenue target for 2030 amid specialty expansion - Investing.com
Hims & Hers Health Faces Strategic Choice Between Semaglutide Expansion or Core Business, BofA Says - marketscreener.com
Hims & Hers Health Weighs Expansion Vs. Core Focus - Finimize
Looking At Hims & Hers Health's Recent Unusual Options Activity - Nasdaq
Hims & Hers Stock Jumps as Q1 Sales More Than Double - Investopedia
Hims & Hers: Strong Q1 Masks Problematic Long-Term Value Proposition (NYSE:HIMS) - Seeking Alpha
Piper Sandler raises Hims & Hers stock target to $39, keeps neutral - Investing.com
Top 1% Stock, Hims & Hers Health, Dives On Lackluster Outlook - MSN
HIMS Stock Sees Profit Pressure Despite Q1 Success | HIMS Stock News - GuruFocus
Hims & Hers (HIMS) Plunges as Weak Outlook Tempers 300% Profit Jump - Yahoo Finance
Hims & Hers (HIMS) Plunges as Weak Outlook Tempers 300% Profit J - GuruFocus
Needham maintains Buy rating on Hims & Hers with $61 price target - Investing.com India
Cowen raises Hims & Hers stock price target to $38, maintains Hold - Investing.com
BofA raises Hims & Hers stock target to $28, retains underperform - Investing.com
Hims and Hers (HIMS) PT Raised to $28 at BofA Securities - StreetInsider
What’s Next For HIMS Stock After A Solid Q1? - Forbes
What’s Next For HIMS Stock After An Upbeat Q1? - Trefis
Hims & Hers Stock Slides Pre-Market As Q2 Sales View Misses Estimates, But Retail Traders Shrug It Off - MSN
Morgan Stanley maintains Hims & Hers stock with $40 target By Investing.com - Investing.com India
BofA maintains Hims & Hers stock underperform, $26 target By Investing.com - Investing.com India
BofA maintains Hims & Hers stock underperform, $26 target - Investing.com
Truist maintains Hims & Hers stock Hold rating, $33 target By Investing.com - Investing.com UK
Hims & Hers Health Inc (HIMS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Hims & Hers Health (NYSE: HIMS) Q1 Earnings: Revenue Surges 111%, Subscribers Up 38%, Q2 Guidance Misses Estimates, Shares Slide - paginasiete.bo
Hims & Hers Health (HIMS) Forecast Disappoints Despite Revenue B - GuruFocus
Hims & Hers Health Reports Strong Q1 2025 Growth - TipRanks
US Consumer Health Market People News: Niagen, INW, Hims & Hers, NOW, Tranont, More - insights.citeline.com
Hims & Hers Health (HIMS) Stock Dips Despite Strong Q1 Results - GuruFocus
Hims & Hers struggles post market despite strong Q1 results and 2025 outlook - Seeking Alpha
Earnings call transcript: Hims & Hers Q1 2025 results show strong growth but miss EPS forecast - Investing.com India
Here's What Key Metrics Tell Us About Hims & Hers Health (HIMS) Q1 Earnings - Yahoo Finance
Market Today: Palantir, Hims & Hers, and Howard Hughes Make Headlines - GuruFocus
Ford, Palantir, Hims earnings breakdowns: Market Domination Overtime - Yahoo Finance
Hims & Hers Health, Inc. (HIMS) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
Hims & Hers Health Exceeds Market Expectations with 111% Revenue Growth in Q1 CY2025News and Statistics - IndexBox
Hims & Hers Health’s (NYSE:HIMS) Q1: Beats On Revenue, Full-Year Outlook Slightly Exceeds Expectations - Yahoo
Hims & Hers Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Hims & Hers Stock Stumbles After Earnings. The Long-Term Sales Outlook Looks Low. - MSN
Hims & Hers Health (HIMS) Sees Strong Q1 Performance with Surging Revenue - GuruFocus
Hims & Hers (HIMS) Blows Out Earnings Expectations - 24/7 Wall St.
Hims & Hers Health Revenue Jumps, But Outlook Disappoints - WSJ
Hims & Hers gives weak outlook but says more collaborations are coming - CNBC
Hims & Hers Health Q1 Earnings, Revenue Rise - marketscreener.com
Hims & Hers Health Q1 Earnings: Revenue Jumps 111%, Subscribers Up 38%, Q2 Guidance Falls Short Of Estimates, Shares SlideHims & Hers Health (NYSE:HIMS) - Benzinga
Hims & Hers stock slips on disappointing Q2 revenue outlook - Yahoo Finance
0.19%
2.41%
자본화:
|
볼륨(24시간):